Visium Asset Management’s Charles River Laboratories CRL Stock Holding History

Visium Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-159,413	Closed	-$10.1M	–	642
2015 Q3	$10.1M	Buy	+159,413	New	+$11.4M	0.14%	162
2015 Q2	–	Sell	-4,705	Closed	-$373K	–	1167
2015 Q1	$373K	Buy	+4,705	New	+$347K	0.01%	749
2014 Q4	–	Sell	-5,394	Closed	-$322K	–	1064
2014 Q3	$322K	Buy	5,394 +1,594	+42%	+$91.2K	﹤0.01%	861
2014 Q2	$203K	Sell	3,800 -25,900	-87%	-$1.42M	﹤0.01%	991
2014 Q1	$1.79M	Buy	29,700 +19,238	+184%	+$1.12M	0.03%	393
2013 Q4	$555K	Sell	10,462 -52,938	-83%	-$2.66M	0.01%	567
2013 Q3	$2.93M	Buy	63,400 +38,265	+152%	+$1.76M	0.07%	225
2013 Q2	$1.03M	Buy	+25,135	New	+$1.08M	0.02%	330

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Visium Asset Management's CRL Position: Q4 2015 in Review

Visium Asset Management sold out of Charles River Laboratories (CRL) in Q4 2015, closing a stake of 159,413 shares — an estimated $10.1M sold.

Visium Asset Management first reported a position in CRL in Q2 2013 and held it in 8 quarters. The position peaked at $10.1M in Q3 2015. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

Visium Asset Management reported no remaining Charles River Laboratories position as of Q4 2015 after selling out during the quarter.
Visium Asset Management sold 159,413 Charles River Laboratories shares in Q4 2015, an estimated $10.1M.
Visium Asset Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 8 quarters.
Visium Asset Management's Charles River Laboratories position peaked at $10.1M in Q3 2015.
268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.